Quest Diagnostics

Global News

Lion Biotechnologies names Molly Henderson chief financial officer

Monday, June 8, 2015 11:13 AM

Lion Biotechnologies, a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), has appointed Molly Henderson, CPA, as chief financial officer, effective immediately.

More... »


Discussing CRA retraining effectively after a monitoring evaluation visit

Monday, June 8, 2015 08:00 AM

Monitoring Evaluation Visits are the means by which sponsors and CROs confirm a Clinical Research Associate’s (CRA) proficiency in conducting monitoring visits.

More... »


Retrophin receives FDA Fast Track for pantothenate kinase-associated neurodegeneration

Friday, June 5, 2015 11:14 AM

The FDA has granted Fast Track designation for RE-024, the Retrophin’s novel investigational phosphopantothenate replacement therapy, for the treatment of pantothenate kinase-associated neurodegeneration (PKAN).

More... »

inVentiv Health names Michael McKelvey EVP, Clinical division president

Friday, June 5, 2015 11:12 AM

Global CRO inVentiv Health has appointed Michael McKelvey, Ph.D., president, inVentiv Health Clinical Division, and executive vice president, inVentiv Health. McKelvey is a seasoned veteran within the CRO industry and has a strong background in clinical development, technology and the development of innovative industry strategies. McKelvey has extensive experience in building and managing successful global organizations in the pharmaceutical services, healthcare, information technologies, life sciences, technology and global core laboratory industries.  

More... »

AMRI, HarkerBIO collaborate

Friday, June 5, 2015 11:07 AM

Albany Molecular Research (AMRI), a CRO based in Albany, N.Y., has signed a collaborative agreement with Buffalo, N.Y.-based biotechnology company HarkerBIO to co-market their structure-based drug discovery services to global pharmaceutical and biotechnology clients. AMRI gains access to HarkerBIO's differentiated high-resolution, structure-determination experience and capabilities. HarkerBIO's customers will be able to access and benefit from AMRI's global capabilities, including their integrated drug discovery platforms and solutions.

More... »

OPKO Health to acquire Bio-Reference Laboratories for $1.5B

Friday, June 5, 2015 11:02 AM

Opko Health, a multinational biopharmaceutical and diagnostics company, has signed a merger agreement to acquire Bio-Reference Laboratories, a Warwick, R.I.-based full service diagnostic laboratory. Bio-Reference Laboratories common stock holders will receive 2.75 shares of Opko common stock for each share of Bio-Reference common stock. Based on a closing price of $19.12 per share of Opko common stock on June 3, the transaction is valued at approximately $1.47 billion, or $52.58 per share of Bio-Reference common stock.

More... »

Rho’s Ronald W. Helms inducted as a Fellow of the Society for Clinical Trials

Thursday, June 4, 2015 02:26 PM

Ronald W. Helms, global CRO Rho’s chairman and co-founder, has been inducted as a Fellow of the Society for Clinical Trials. The Society established the title of Fellow of the Society for Clinical Trials (FSCT) in 2005 to honor society members who have made significant contributions to the advancement of clinical trials and to the society.

More... »

Sanguine expands services into the clinical space

Thursday, June 4, 2015 01:37 PM

Sanguine, a Los Angeles, Calif.-based technology company providing services to the personalized medicine and biomedical research market, is expanding its services to improve clinical trial efficiency through enhanced patient recruitment, retention and trial procedures. Sanguine, which primarily operated in the preclinical space until now, will be fulfilling needs in later stage clinical development through a combination of smart technology and adaptable mobile health force.

More... »

Veristat expands, relocates headquarters in Massachusetts

Thursday, June 4, 2015 01:37 PM

CRO Veristat has announced plans to move the company’s corporate headquarters from Holliston, Mass., to Southborough, Mass., this coming summer. The move is driven by Veristat’s rapid growth in response to the increased demand for full-service clinical research offerings by its pharmaceutical and biotechnology clients.

More... »

PDI, White House, CDC partner to combat antimicrobial resistance

Thursday, June 4, 2015 01:32 PM

PDI, a U.S. healthcare company, has announced a series of corporate commitments designed to educate internal associates and customers about strategies to reduce the threat of antimicrobial-resistant microorganisms as part of its ongoing partnership with the U.S. Centers for Disease Control and Prevention (CDC) and in support of The White House's National Strategy to Combat Antibiotic-Resistant Bacteria.

More... »

`

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs